Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neuroblastoma 3 Ganglioneuroblastoma 2 Wilms Tumor 1 Neoplasms 1 Kidney Neoplasms 1

Interventions

cabozantinib 5 Nivolumab 4 Ipilimumab 4 Axitinib 4 pembrolizumab 3 Blood Specimen Collection 3 zimberelimab 2 atezolizumab 2 Surveys and Questionnaires 2 Sunitinib 2 Irinotecan 2 temsirolimus 1 spartalizumab 1 salicylhydroxamic acid 1 palbociclib 1 orellanine 1 olaparib 1 liposomal doxorubicin 1 lenvatinib 1 gallium Ga 68 dotatate 1 fludarabine 1 brodalumab 1 belzutifan 1 aldesleukin 1 adagrasib 1 Vincristine 1 Temozolomide 1 Taxes 1 Selenomethionine 1 Ropivacaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Kidney Neoplasms × Isotretinoin × 90 days × Clear all

NCT05384821 2026-03-18

MetroWilms

Centre Oscar Lambret

Phase 1/2 Recruiting

Kidney Neoplasms, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡